Breast Lesion Localization Methods Market Is Getting Traction Due To Rising Awareness Through Cancer Screening Programs
The
global breast lesion localization methods market is
expected to reach USD 1.57 billion by 2025, according to a new report by Grand
View Research, Inc. The increasing government and non-government reimbursement
policies for mammary gland cancer diagnosis, biopsy, pre-surgical examinations,
and other treatment options is estimated to increase the adoption of breast
lesion localization procedures. For instance, the Alabama Breast and Cervical
Cancer Early Detection Program aims to provide breast and cervical oncology
diagnostic and screening services to women who meet certain income, age, and
insurance coverage eligibility guidelines.
U.S. breast lesion localization methods, by type, 2014 - 2025 (USD Billion) |
Furthermore,
rising prevalence of breast cancer is anticipated to propel the market growth.
The disease is highly prevalent amongst women belonging to the age group of 65
years or above. The maximum risk of mammary gland cancer is between the age of
70 and 79. On the other hand, men are also at a risk of breast cancer. In the
U.S., median age of men at diagnosis is approximately 68 years.
Browse full
research report on Breast Lesion Localization Methods Market: www.grandviewresearch.com/industry-analysis/breast-lesion-localization-methods-market
Further
key findings from the report suggest:
- Wire localization biopsy dominated the market
in 2016 owing to its higher usage by healthcare practitioners, easy
availability, and presence of a wide product range
- Magnetic tracer is expected to grow at
lucrative CAGR of 14.0% over the forecast period as a result of increasing
adoption of MagSNOLL technology over conventional wire localization.
- Radioisotope seed localization is considered
the most preferred method amongst all radioisotope localization methods
due to its benefits such as ease of localization few weeks before the
excision surgery and lesser need for reoperation.
- North America is estimated to be the largest
regional market. It dominated the market in terms of revenue with USD
185.04 million in 2016 owing to the presence of well-established
healthcare services and increasing number of oncology surgeries being
performed.
- In addition, early adoption of devices and
shift from traditional to technologically advanced products by healthcare
providers are some of the factors anticipated to increase the demand for
localization devices in this region
- Asia Pacific is expected to be the fastest
growing region over the next decade with lucrative CAGR from 2017 to 2025
due to growing awareness about breast screening among the people.
Furthermore, presence of a large target population and rising disposable
income are some of the factors expected to propel the growth of this
region.
- Key players in this industry are Cianna
Medical, Inc.; Cook Medical; STERYLAB; CP Medical; SOMATEX Medical
Technologies; Argon Medical Devices, Inc.; and C.R BARD, Inc.
- Most of the key players are focusing on
strategies such as expansion of their product portfolios and
collaborations, mergers, & acquisitions. In November 2015, C.R. BARD,
Inc. announced the acquisition of Liberator Medical Holdings, Inc., a
direct-to-customer distributor of medical products.
Browse more
reports of this category by Grand View Research: www.grandviewresearch.com/industry/healthcare
Grand View Research has segmented the global breast lesion localization
methods market on the basis of type and region:
Breast
Lesion Localization Methods Type Outlook (Revenue, USD Million, 2014 - 2025)
- Wire
Localization biopsy
- Radioisotope
localization
- Radio-guided
occult lesion localization
- Radioactive
seed localization
- Others
- Magnetic
tracer
- Others
Breast
Lesion Localization Methods Regional Outlook (Volume, Tons; Revenue, USD
Million, 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia
Pacific
- Japan
- China
- India
- Latin
America
- Brazil
- Mexico
- Middle
East & Africa
- South
Africa
Access
Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-breast-lesion-localization-methods-market
About Grand
View Research:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The company
provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
Comments
Post a Comment